Cullinan Therapeutics has filed an investigational new drug application with the U.S. Food and Drug Administration (FDA) for CLN-978 for the treatment of systemic lupus erythematosus (SLE).

An all-electric sedan will eventually succeed the iconic Phantom. Rolls-Royce will continue to build the V12-powered Cullinan ...

Mansory specializes in customizing cars, but throughout its history has worked on a variety of vehicles including golf carts ...

Andy Ruiz Jr. is gearing up for his return to the boxing ring and continues his training in one of his many gyms. His latest ...

Cannabis seeds are being sold at garden centers and nurseries in the Capital Region, and because of low-THC levels, without ...

Nicholas Cullinan, the new director of the British Museum, has announced a groundbreaking $1.3 billion transformation plan, ...

Phase 1 clinical trial is designed to assess the safety, pharmacokinetics and initial clinical activity of CLN-978 for ...

Why did Mukesh Ambani buy India's first Rolls Royce Cullinan Series II? Explore the latest addition to his collection and the ...

The newly-evolved Rolls-Royce Cullinan Series II appeals to the discerning tastes of ultra-luxury SUV enthusiasts through ...

The Human Research Ethics Committee (HREC) in Australia has granted clearance for Cullinan Therapeutics to commence an ...

Petra Diamonds’ Cullinan mine has successfully launched its Gumboot Recycling Project to reduce plastic waste while ...

Rolls-Royce has unveiled the Cullinan Series II, marking a bold evolution of its renowned super-luxury SUV. This latest ...